2017
DOI: 10.1111/imcb.1025
|View full text |Cite
|
Sign up to set email alerts
|

Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis

Abstract: Multiple sclerosis (MS) is an immune mediated, inflammatory and demyelinating disease of the central nervous system (CNS). Substantial evidence points toward monocytes and macrophages playing prominent roles early in disease, mediating both pro‐ and anti‐inflammatory responses. Monocytes are subdivided into three subsets depending on the expression of CD14 and CD16, representing different stages of inflammatory activation. To investigate their involvement in MS, peripheral blood mononuclear cells from 40 patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

6
65
2

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(77 citation statements)
references
References 67 publications
6
65
2
Order By: Relevance
“…Patients with HT were also characterized by an increased frequency of CD86 + non-classical Mo, which has been previously reported in patients with other autoimmune diseases including multiple sclerosis (37), systemic lupus erythematous (38), and primary biliary cirrhosis (39). Variations in sample material, separation protocols, detection methodology and definition of Mo subsets might explain why we did not detect a parallel reduction of classical Mo as observed in other studies (38,39).…”
Section: Discussionsupporting
confidence: 67%
“…Patients with HT were also characterized by an increased frequency of CD86 + non-classical Mo, which has been previously reported in patients with other autoimmune diseases including multiple sclerosis (37), systemic lupus erythematous (38), and primary biliary cirrhosis (39). Variations in sample material, separation protocols, detection methodology and definition of Mo subsets might explain why we did not detect a parallel reduction of classical Mo as observed in other studies (38,39).…”
Section: Discussionsupporting
confidence: 67%
“…Similar to our results, lower amounts of CD14++ monocytes have been described in patients with multiple sclerosis (MS) [34] and juvenile idiopathic arthritis (JIA) with enthesitis [35]. Besides, a higher percentage of CD16+ intermediate and non-classical monocytes with a pro-inflammatory phenotype has been described in patients with MS [34], neuromyelitis optica [36], RA [18], SLE [37], ANCA-vasculitis [38], sarcoidosis [39], IgA nephropathy [40], JIA with enthesitis [35], type 1 diabetes mellitus [41], thromboembolism [42], atherosclerosis and stroke [43] which is according to our results. Also, we found that the absolute number of classical monocytes inversely correlated with the disease activity (MYOACT and MITAX), which is according with previous data in patients with RA, where there is a higher percentage of intermediate monocytes during disease activity and a higher proportion of classical monocytes during remission [44].…”
Section: Discussionsupporting
confidence: 92%
“…In addition, the human genome contains several HERVs followed by poly(A) tails that are in fact LINE-processed pseudogenes from HERV mRNAs (Pavlícek et al 2002). These pseudogenes are remarkably numerous in the HERV-W family, that is one of the most frequently associated with MS (see for example (Gjelstrup et al 2018)). It is therefore tempting to speculate that poly(A) tracts, scars of LINE/SINE retro-transposition events, provide increased stability to some HERV-encoding transcripts and possibly allow for their occasional translation.…”
Section: Discussionmentioning
confidence: 99%